BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 24
• 25
• 28
• 29
• 30

• Bio NC

  Oxygen Biotherapeutics, Inc. Files Patent Application for Emergency Heart Attack Treatment Device

  September 24, 2009

   · 

  3 min read
• Business

  Catalent Pharma Solutions And GlaxoSmithKline Extend Contractual Agreement

  September 24, 2009

   · 

  1 min read
• BioCapital

  RegeneRx Biopharmaceuticals, Inc. to Present Several Papers at Second International Symposium on Thymosins in Health and Disease

  September 24, 2009

   · 

  1 min read
• Business

  Amsterdam Molecular Therapeutics (AMT) Appoints Jorn Aldag as New Chief Executive Officer

  September 24, 2009

   · 

  4 min read
• Genetown

  SPIRIT IV Results Reaffirm Strong Performance of Boston Scientific Corporation PROMUS(R) and TAXUS(R) Express(R) Stents

  September 24, 2009

   · 

  3 min read
• Biotech Bay

  Volcano Corporation Praises FAME Study Results

  September 24, 2009

   · 

  3 min read
• Drug Development

  ThromboGenics NV Completes Patient Enrolment in US Phase III Trial of Microplasmin for the Non-Surgical Treatment of Eye Disease

  September 24, 2009

   · 

  5 min read
• Drug Development

  Alimera Sciences Begins Pilot Study of Iluvien(R) in Patients With Macular Edema Secondary to Retinal Vein Occlusion

  September 24, 2009

   · 

  2 min read
• Drug Development

  Morphotek Inc.: Farletuzumab Data Presented on Phase II Clinical Trial in First-Relapsed Ovarian Cancer Subjects

  September 24, 2009

   · 

  5 min read
• BioCapital

  Spherix Announces Annual Shareholders Meeting Date

  September 24, 2009

   · 

  3 min read